Development of orthogonal NISTmAb size heterogeneity control methods.

Printer-friendly versionPrinter-friendly versionPDF versionPDF version
TitleDevelopment of orthogonal NISTmAb size heterogeneity control methods.
Publication TypeJournal Article
Year of Publication2018
AuthorsTurner, A, Yandrofski, K, Telikepalli, S, King, J, Heckert, A, Filliben, J, Ripple, D, Schiel, JE
JournalAnal Bioanal Chem
Volume410
Issue8
Pagination2095-2110
Date Published2018 Mar
ISSN1618-2650
Abstract

The NISTmAb is a monoclonal antibody Reference Material from the National Institute of Standards and Technology; it is a class-representative IgG1κ intended to serve as a pre-competitive platform for harmonization and technology development in the biopharmaceutical industry. The publication series of which this paper is a part describes NIST's overall control strategy to ensure NISTmAb quality and availability over its lifecycle. In this paper, the development of a control strategy for monitoring NISTmAb size heterogeneity is described. Optimization and qualification of size heterogeneity measurement spanning a broad size range are described, including capillary electrophoresis-sodium dodecyl sulfate (CE-SDS), size exclusion chromatography (SEC), dynamic light scattering (DLS), and flow imaging analysis. This paper is intended to provide relevant details of NIST's size heterogeneity control strategy to facilitate implementation of the NISTmAb as a test molecule in the end user's laboratory. Graphical abstract Representative size exclusion chromatogram of the NIST monoclonal antibody (NISTmAb). The NISTmAb is a publicly available research tool intended to facilitate advancement of biopharmaceutical analytics. HMW = high molecular weight (trimer and dimer), LMW = low molecular weight (2 fragment peaks). Peak labeled buffer is void volume of the column from L-histidine background buffer.

DOI10.1007/s00216-017-0819-3
Alternate JournalAnal Bioanal Chem
PubMed ID29428991
PubMed Central IDPMC5830496